Physician profile
George E Green
NPI 1811074875
$3,829.74
in general payments reported to CMS, 2019-2025
17 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $337 · 2021: $482 · 2022: $253 · 2023: $379 · 2024: $593 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,638.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $1,095.66 | 2019-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $689.76 | 2019-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $561.25 | 2019-2025 | Nucala, Trelegy Ellipta |
| Amgen INC. | $471.33 | 2019-2025 | Otezla, Repatha, Repatha |
| Electromed, INC. | $145.88 | 2019-2024 | Smartvest |
| Janssen Pharmaceuticals, INC | $140.06 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $122.63 | 2023-2024 | |
| Heartflow, INC. | $120.30 | 2024 | |
| Esperion Therapeutics, INC. | $102.91 | 2020-2025 | Nexletol |
| Astrazeneca Pharmaceuticals Lp | $83.65 | 2021-2024 | Farxiga |
| Philips North America LLC | $82.88 | 2020-2025 | (8874) Incourage, Vest Therapy Und |
| Inspire Medical Systems, INC. | $60.95 | 2023 | Inspire |
| Avanir Pharmaceuticals, INC. | $55.25 | 2021-2022 | |
| Baxter Healthcare | $46.94 | 2025 | Hillrom - Volara System |
| Arcutis Biotherapeutics, INC. | $20.44 | 2024 | Zoryve |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.33 | 2019 | |
| Allergan, INC. | $14.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.